Views

CrossRef citations to date

Altmetric

Letters to the Editor

Excess of deaths for patients with plasma cell proliferative disorders as a result of the COVID-19 pandemic

Tom Dunnea Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada

https://orcid.org/0000-0003-0596-3490

Douglas Stewarta Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada

https://orcid.org/0000-0001-5531-0960

Holly Leea Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada

Jason Taya Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada

Peter Duggana Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada

Sylvia McCullocha Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada

Paola Neria Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada;b Charbonneau Cancer Research Institute, Calgary, Canada

Nizar J. Bahlisa Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada;b Charbonneau Cancer Research Institute, Calgary, Canada

Victor H. Jimenez-Zepedaa Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada;b Charbonneau Cancer Research Institute, Calgary, CanadaCorrespondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Compliance with ethical standards

This study did not receive any funding.

Approval for the review of these records was obtained from the TBCC Institutional Review Board and Informed consent was also obtained.

This study was performed in accordance with the ethical standards of TBCC research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent was obtained from patients to participate in this project and our Institutional database.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Excess of deaths for patients with plasma cell proliferative disorders as a result of the COVID-19 pandemic

Information for

Open access

Opportunities

Help and information

Excess of deaths for patients with plasma cell proliferative disorders as a result of the COVID-19 pandemic

Compliance with ethical standards

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature